Quotient Sciences Quotient Sciences

X

Digital content for TransThera Biosciences

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
TransThera Biosciences
China Flag
Country
Country
China
Address
Address
Floor 3, Building 9, Phase 2 Accelerator, Biopharma Valley, Jiangbei New Area, Nanjing
Telephone
Telephone
025-86901057
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/transthera-announced-global-phase-3-clinical-trial-for-cholangiocarcinoma-authorized-in-the-european-union-and-orphan-drug-designation-for-tinengotinib-to-treat-biliary-tract-cancer-granted-by-european-medicines-agency-302084086.html

PR NEWSWIRE
08 Mar 2024

https://www.prnewswire.com/news-releases/transthera-initiates-ind-enabling-studies-for-tt-02332-a-novel-highly-potent-and-cns-penetrating-nlrp3-inhibitor-302070999.html

PR NEWSWIRE
26 Feb 2024

https://www.prnewswire.com/news-releases/transthera-announces-the-global-multicenter-phase-3-clinical-trial-completed-first-patient-dosing-in-the-us-evaluating-tinengotinib-in-fgfri-relapsedrefractory-patients-with-cholangiocarcinoma-302021004.html

PR NEWSWIRE
21 Dec 2023

https://www.prnewswire.com/news-releases/2023-sabcs---transthera-announces-an-oral-presentation-of-tinengotinib-clinical-data-in-breast-cancer-302008583.html

PR NEWSWIRE
07 Dec 2023

https://www.prnewswire.com/news-releases/transthera-announces-two-oral-presentations-of-tinengotinib-clinical-data-at-2023-esmo-and-sabcs-annual-meetings-301950709.html

PR NEWSWIRE
09 Oct 2023

https://www.pharmaceutical-technology.com/news/fda-transthera-b-cell-lymphoma/

PHARMACEUTICAL-TECHNOLOGY
22 Feb 2022

https://www.prnewswire.com/news-releases/transthera-announces-that-the-ind-application-of-tt-01488-a-non-covalent-reversible-btk-inhibitor-for-the-treatment-of-b-cell-lymphomas-has-been-approved-by-the-fda-in-the-us-and-officially-accepted-by-the-nmpa-in-china-301485640.html

PRNEWSWIRE
18 Feb 2022

https://en.prnasia.com/releases/global/transthera-announces-collaboration-with-roche-to-evaluate-tt-00420-as-part-of-a-novel-combination-to-treat-gi-cancers-in-china-319994.shtml

PRNASIA
26 May 2021

https://www.prnewswire.com/news-releases/transthera-announces-collaboration-with-roche-to-evaluate-tt-00420-as-part-of-a-novel-combination-to-treat-gi-cancers-in-china-301299701.html

PRNEWSWIRE
26 May 2021

https://www.prnewswire.com/news-releases/transthera-announces-collaboration-with-roche-to-evaluate-tt-00420-as-part-of-a-novel-combination-to-treat-gi-cancers-in-china-301299701.html

PRNEWSWIRE
26 May 2021
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY